We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Retrospective study compares efficacy and safety of chemotherapy regimens in HER2-positive breast cancer, suggesting anthracycline-free may reduce cardiac risks.
No takes yet. Share an insight, caveat, or question.
Kara et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: